ANIP Ani Pharmaceuticals margins

Relative Growth: Rel. Growth:

Relative Strength: Rel. Strength:

Relative Valuation: Rel. Valuation:

Relative Profitability: Rel. Profitability: 93

Gross margin

61.1%

Operating margin

15.4%

EBITDA margin

24.7%

Net margin

11.2%

At present, Ani Pharmaceuticals reports a gross margin of 61.1%, an operating margin of 15.4%, an EBITDA margin of 24.7%, and a net margin of 11.2%. The strongest improvement was in operating margin, up 10.2 percentage points; the remaining margins remained unchanged.

ANIP margin history

Gross, operating, EBITDA and net margin trends

Ani Pharmaceuticals's margins averaged 60.92% gross, 7.07% operating, 19.39% EBITDA, and 4.43% net during the last 3 years. Currently all four current margins are above their three-year averages.

ANIP margin expansion

Year-over-year margin changes in percentage points

From the same period last year, operating margin expanded by 10.2 percentage points, EBITDA margin by 4.7 percentage points, and net margin by 6.3 percentage points, while gross margin was unchanged.

Gross margin expansion

0pp

Operating margin expansion

10.2pp

EBITDA margin expansion

4.7pp

Net margin expansion

6.3pp

ANIP Gross margin

Over the last 3 years, the average gross margin for Ani Pharmaceuticals was 60.92%. The latest gross margin for Ani Pharmaceuticals is 61.1%, 0.2 percentage points above its three-year average. Ani Pharmaceuticals's gross margin ranged from a low of 59.3% in Dec 2024 to a high of 62.7% in Mar 2024.

ANIP Operating margin

Over the last 3 years, Ani Pharmaceuticals's operating margin averaged 7.07%. Right now, Ani Pharmaceuticals's current operating margin is 15.4%, which is 8.3 percentage points above its three-year average. During this period, operating margin reached a high of 15.4% in Sep 2026 and a low of -1.5% in Mar 2025.

ANIP EBITDA margin

The average EBITDA margin for Ani Pharmaceuticals was 19.39% during the last 3 years. At present, the current EBITDA margin for Ani Pharmaceuticals is 24.7%, 5.3 percentage points above its three-year average. The EBITDA margin for Ani Pharmaceuticals moved between 10.2% in Mar 2025 and 25.2% in Jun 2026.

ANIP Net margin

Looking back over the last 3 years, Ani Pharmaceuticals recorded an average net margin of 4.43%. Ani Pharmaceuticals currently reports a net margin of 11.2%, 6.8 percentage points above its three-year average. The highest net margin for Ani Pharmaceuticals was 11.2% in Sep 2026, while the lowest was -3.1% in Mar 2025.

ANIP margin group comparison

Margins compared with peer-group, industry and sector averages

With a gross margin of 61.1%, ANIP stands lower than the Healthcare sector, the industry and its peers average. Looking at the Healthcare sector average of 68.3%, Ani Pharmaceuticals's gross margin is 11% lower.

ANIP margin peer comparison

Compare margins with selected peers

Frequently asked questions

What is Ani Pharmaceuticals's gross margin?

The current gross margin for ANIP is 61.1% as of Sep 30, 2026.

What is Ani Pharmaceuticals's operating margin?

The current operating margin for ANIP is 15.4% as of Sep 30, 2026.

What is Ani Pharmaceuticals's EBITDA margin?

For the period ending Sep 30, 2026, ANIP recorded an EBITDA margin of 24.7%.

What is Ani Pharmaceuticals's net margin?

For the period ending Sep 30, 2026, ANIP recorded a net margin of 11.2%.

What are the average margins of ANIP?

Over the last 3 years, Ani Pharmaceuticals's margins averaged 60.9% gross, 7.1% operating, 19.4% EBITDA, and 4.4% net.

What are the highest historical margins of ANIP?

Over this 5-year history, ANIP peaked at 63.4% gross in Sep 2023, 15.4% operating in Sep 2026, 25.2% EBITDA in Jun 2026, and 11.2% net in Sep 2026.

What are the lowest historical margins of ANIP?

In the last 5 years, the lowest margins reported by ANIP were 49.1% gross in Jun 2022, -28.6% operating in Mar 2022, -6.7% EBITDA in Mar 2022, and -27.8% net in Mar 2022.